1. Home
  2. OC vs KRYS Comparison

OC vs KRYS Comparison

Compare OC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Owens Corning Inc New

OC

Owens Corning Inc New

HOLD

Current Price

$150.28

Market Cap

9.6B

Sector

Industrials

ML Signal

HOLD

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$370.07

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OC
KRYS
Founded
1938
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
10.3B
IPO Year
2006
2017

Fundamental Metrics

Financial Performance
Metric
OC
KRYS
Price
$150.28
$370.07
Analyst Decision
Buy
Strong Buy
Analyst Count
11
11
Target Price
$145.27
$297.60
AVG Volume (30 Days)
1.4M
331.4K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
2.61%
N/A
EPS Growth
N/A
128.00
EPS
N/A
1.83
Revenue
N/A
$389,130,000.00
Revenue This Year
N/A
$38.74
Revenue Next Year
$3.72
$32.53
P/E Ratio
N/A
$204.58
Revenue Growth
N/A
33.94
52 Week Low
$97.53
$130.50
52 Week High
$159.91
$382.54

Technical Indicators

Market Signals
Indicator
OC
KRYS
Relative Strength Index (RSI) 66.46 71.51
Support Level $115.22 $246.17
Resistance Level N/A N/A
Average True Range (ATR) 7.07 13.79
MACD 2.90 2.81
Stochastic Oscillator 74.60 81.32

Price Performance

Historical Comparison
OC
KRYS

About OC Owens Corning Inc New

Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: